Investors
Segment Data and Regional Results
The audited BASF Report 2024 will be published on March 21, 2025. The key financial figures published on February 28, 2025, are therefore to be regarded as preliminary. From today’s perspective, no adjustments are expected.
BASF Report 2024
Segment Data
Segment data — Chemicals
| Million € | 2024 | 2023 | +/- |
| Sales to third parties | 10,838 | 10,369 | 4.5% |
|
of which Petrochemicals |
8,050 | 7,418 | 8.5% |
|
Intermediates |
2,788 | 2,951 | -5.5% |
| Intersegment transfers | 3,962 | 3,606 | 9.9% |
| Sales including transfers | 14,800 | 13,975 | 5.9% |
| EBITDA before special items | 1,342 | 1,167 | 15.0% |
| Special items in EBITDA | –28 | 0 | . |
| EBITDA | 1,314 | 1,167 | 12.6% |
| EBITDA margin before special items (%) | 12.4 | 11.3 | − |
|
Depreciation and amortizationa |
885 | 803 | 10.3% |
| EBIT before special items | 503 | 361 | 39.4% |
| Special items in EBIT | –74 | 4 | . |
| Income from operations (EBIT) | 429 | 364 | 17.7% |
| Investments including acquisitionsb | 3,403 | 2,706 | 25.8% |
| Segment cash flow | –2.051 | –936 | -119.2% |
| Assets (December 31) | 14,266 | 11,468 | 24.4% |
| Research and development expenses | 80 | 83 | -4.4% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data — Materials
| Million € | 2024 | 2023 | +/- |
| Sales to third parties | 13,510 | 14,149 | -4.5% |
|
of which Performance Materials |
6,848 | 7,244 | -5.5% |
|
Monomers |
6,661 | 6,905 | -3.5% |
| Intersegment transfers | 825 | 864 | -4.5% |
| Sales including transfers | 14,335 | 15,013 | -4.5% |
| EBITDA before special items | 1,805 | 1,650 | 9.4% |
| Special items in EBITDA | –37 | –127 | 71.1% |
| EBITDA | 1,769 | 1,523 | 16.1% |
| EBITDA margin before special items (%) | 13.4 | 11.7 | − |
|
Depreciation and amortizationa |
830 | 1,146 | -27.6% |
| EBIT before special items | 987 | 826 | 19.4% |
| Special items in EBIT | –48 | –449 | 89.2% |
| Income from operations (EBIT) | 939 | 378 | 148.6% |
| Investments including acquisitionsb | 1,139 | 1,083 | 5.2% |
| Segment cash flow | 766 | 1,369 | -44.1% |
| Assets (December 31) | 10,135 | 9,716 | 4.3% |
| Research and development expenses | 180 | 185 | -2.7% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data — Industrial Solutions
| Million € | 2024 | 2023 | +/- |
| Sales to third parties | 8,175 | 8,010 | 2.1% |
|
of which Dispersions & Resins |
5,110 | 4,921 | 3.8% |
|
Performance Chemicals |
3,065 | 3,088 | -0.7% |
| Intersegment transfers | 385 | 436 | -11.7% |
| Sales including transfers | 8,560 | 8,445 | 1.4% |
| EBITDA before special items | 1,161 | 965 | 20.3% |
| Special items in EBITDA | –22 | 45 | . |
| EBITDA | 1,140 | 1,010 | 12.8% |
| EBITDA margin before special items (%) | 14.2 | 12.0 | − |
|
Depreciation and amortizationa |
360 | 349 | 3.0% |
| EBIT before special items | 811 | 625 | 29.8% |
| Special items in EBIT | –32 | 35 | . |
| Income from operations (EBIT) | 780 | 660 | 18.1% |
| Investments including acquisitionsb | 289 | 285 | 1.3% |
| Segment cash flow | 868 | 1,292 | -32.8% |
| Assets (December 31) | 5,629 | 5,576 | 1.0% |
| Research and development expenses | 144 | 150 | -3.9% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data — Nutrition & Care
| Million € | 2024 | 2023 | +/- |
| Sales to third parties | 6,729 | 6,858 | -1.9% |
|
of which Care Chemicals |
4,751 | 4,721 | 0.7% |
|
Nutrition & Health |
1,978 | 2,137 | -7.4% |
| Intersegment transfers | 446 | 429 | 4.1% |
| Sales including transfers | 7,176 | 7,286 | -1.5% |
| EBITDA before special items | 814 | 565 | 44.0% |
| Special items in EBITDA | 5 | 12 | -56.8% |
| EBITDA | 819 | 578 | 41.8% |
| EBITDA margin before special items (%) | 12.1 | 8.2 | − |
|
Depreciation and amortizationa |
599 | 459 | 30.6% |
| EBIT before special items | 273 | 107 | 155.9% |
| Special items in EBIT | –53 | 12 | . |
| Income from operations (EBIT) | 220 | 119 | 84.8% |
| Investments including acquisitionsb | 809 | 765 | 5.8% |
| Segment cash flow | –31 | 503 | . |
| Assets (December 31) | 7,887 | 7,496 | 5.2% |
| Research and development expenses | 149 | 150 | -0.7% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data — Surface Technologies
| Million € | 2024 | 2023 | +/- |
| Sales to third parties | 12,898 | 16,204 | -20.4% |
|
of which Catalysts |
8,617 | 11,818 | -27.1% |
|
Coatings |
4,280 | 4,387 | -2.4% |
| Intersegment transfers | 206 | 176 | 17.0% |
| Sales including transfers | 13,104 | 16,381 | -20.0% |
| EBITDA before special items | 1,375 | 1,520 | -9.5% |
| Special items in EBITDA | –215 | –168 | -27.9% |
| EBITDA | 1,160 | 1,351 | -14.2% |
| EBITDA margin before special items (%) | 10.7 | 9.4 | − |
|
Depreciation and amortizationa |
1,137 | 986 | 15.4% |
| EBIT before special items | 786 | 938 | -16.3% |
| Special items in EBIT | –763 | –572 | -33.3% |
| Income from operations (EBIT) | 22 | 366 | -93.9% |
| Investments including acquisitionsb | 560 | 621 | -9.8% |
| Segment cash flow | 925 | 1,488 | -37.8% |
| Assets (December 31) | 11,513 | 12,657 | -9.0% |
| Research and development expenses | 313 | 304 | 2.9% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data — Agricultural Solutions
| Million € | 2024 | 2023 | +/- |
| Sales to third parties | 9,798 | 10,092 | -2.9% |
|
of which Fungicides |
3,014 | 3,047 | -1.1% |
|
Herbicides |
2,965 | 3,380 | -12.3% |
|
Insecticides |
1,102 | 1,041 | 5.9% |
|
Seed Treatment |
598 | 662 | -9.6% |
|
Seeds & Traits |
2,119 | 1,962 | 8.0% |
| Intersegment transfers | 50 | 36 | 39.1% |
| Sales including transfers | 9,848 | 10,128 | -2.8% |
| EBITDA before special items | 1,938 | 2,270 | -14.6% |
| Special items in EBITDA | –279 | –93 | -200.7% |
| EBITDA | 1,659 | 2,177 | -23.8% |
| EBITDA margin before special items (%) | 19.8 | 22.5 | − |
|
Depreciation and amortizationa |
675 | 1,046 | -35.4% |
| EBIT before special items | 1,270 | 1,563 | -18.8% |
| Special items in EBIT | –286 | –433 | 33.9% |
| Income from operations (EBIT) | 984 | 1,131 | -13.0% |
| Investments including acquisitionsb | 387 | 353 | 9.7% |
| Segment cash flow | 1,861 | 1,746 | 6.6% |
| Assets (December 31) | 15,377 | 16,089 | -4.4% |
| Research and development expenses | 919 | 900 | 2.0% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Financial data — Other
| Million € | 2024 | 2023 | +/- |
| Sales to third parties | 3,312 | 3,220 | 2.8% |
| EBITDA before special items | –578 | –466 | -24.0% |
|
of which costs for cross-divisional corporate research |
–183 | –227 | 19.4% |
|
costs of corporate headquarters |
–232 | –222 | -4.4% |
|
other businesses |
171 | 200 | -14.6% |
|
miscellaneous income and expenses |
–334 | –218 | -53.6% |
| Special items in EBITDA | –601 | –159 | -277.0% |
| EBITDA | –1,179 | –626 | -88.5% |
| Depreciation and amortizationa | 161 | 153 | 5.5% |
| EBIT before special items | –718 | –614 | -16.9% |
| Special items in EBIT | –622 | –164 | -279.1% |
| Income from operations (EBIT) | –1,340 | –778 | -72.2% |
| Investments including acquisitionsb | 241 | 195 | 23.2% |
| Assets (December 31)c | 15,609 | 14,393 | 8.4% |
| Research and development expenses | 276 | 356 | -22.5% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
c Includes assets of businesses recognized under Other and reconciliation to assets of the BASF Group
Regions
| Million € | Sales by location of company |
Sales by location of customer |
||||
| 2024 | 2023 | +/- | 2024 | 2023 | +/- | |
| Europe | 26,169 | 27,631 | –5.3% | 24,778 | 26,022 | –4.8% |
|
of which Germany |
11,016 | 11,449 | –3.8% | 6,138 | 6,833 | –10.2% |
| North America | 18,168 | 19,003 | –4.4% | 17,773 | 18,833 | –5.6% |
| Asia Pacific | 15,886 | 17,142 | –7.3% | 16,226 | 17,520 | –7.4% |
|
of which Greater China |
8,706 | 9,427 | –7.7% | 8,599 | 9,366 | –8.2% |
| South America, Africa, Middle East | 5,037 | 5,126 | –1.7% | 6,482 | 6,527 | –0.7% |
| BASF Group | 65,260 | 68,902 | –5.3% | 65,260 | 68,902 | –5.3% |